Abstract

Neutrophils sense and migrate towards chemotactic factors released at sites of infection/inflammation and contain the affected area using a variety of effector mechanisms. Aside from these established immune defense functions, neutrophils are emerging as one of the key tumor-infiltrating immune cells that influence cancer progression and metastasis. Neutrophil recruitment to the tumor microenvironment (TME) is mediated by multiple mediators including cytokines, chemokines, lipids, and growth factors that are secreted from cancer cells and cancer-associated stromal cells. However, the molecular mechanisms that underlie the expression and secretion of the different mediators from cancer cells and how neutrophils integrate these signals to reach and invade tumors remain unclear. Here, we discuss the possible role of the epithelial to mesenchymal transition (EMT) program, which is a well-established promoter of malignant potential in cancer, in regulating the expression and secretion of these key mediators. We also summarize and review our current understanding of the machineries that potentially control the secretion of the mediators from cancer cells, including the exocytic trafficking pathways, secretory autophagy, and extracellular vesicle-mediated secretion. We further reflect on possible mechanisms by which different mediators collaborate by integrating their signaling network, and particularly focus on TGF-β, a cytokine that is highly expressed in invasive tumors, and CXCR2 ligands, which are crucial neutrophil recruiting chemokines. Finally, we highlight gaps in the field and the need to expand current knowledge of the secretory machineries and cross-talks among mediators to develop novel neutrophil targeting strategies as effective therapeutic options in the treatment of cancer.

Highlights

  • Neutrophils are the body’s first responders to injury or infection

  • While studies have focused on understanding the tumor promoting or impairing properties of neutrophils, many questions remain unanswered about the identity of the mediators that control neutrophil recruitment to tumor sites and the function of tumor-associated neutrophils, referred to as TANs

  • We present an overview of the functions of TANs and the different classes of mediators that have been linked to neutrophil recruitment to tumors, discuss how cancer-associated changes such as the epithelial to mesenchymal transition (EMT) upregulate the expression of the mediators, and review the secretory mechanisms that potentially underlie the release of the mediators in the tumor microenvironment (TME)

Read more

Summary

Frontiers in Immunology

Neutrophils sense and migrate towards chemotactic factors released at sites of infection/ inflammation and contain the affected area using a variety of effector mechanisms. Aside from these established immune defense functions, neutrophils are emerging as one of the key tumor-infiltrating immune cells that influence cancer progression and metastasis. The molecular mechanisms that underlie the expression and secretion of the different mediators from cancer cells and how neutrophils integrate these signals to reach and invade tumors remain unclear. We further reflect on possible mechanisms by which different mediators collaborate by integrating their signaling network, and focus on TGF-b, a cytokine that is highly expressed in invasive tumors, and CXCR2 ligands, which are crucial neutrophil recruiting chemokines.

INTRODUCTION
PLASTICITY OF NEUTROPHILS IN CANCER
DIFFUSIBLE MEDIATORS IN THE TUMOR NICHE
Potential impact on neutrophils
MECHANISMS REGULATING THE SECRETION OF DIFFUSIBLE MEDIATORS FROM CANCER CELLS
Epithelial to Mesenchymal Transition
AUTHOR CONTRIBUTIONS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.